COMPANY
ENDRA Life Sciences
Raises and investors new
- Raise Private raise (SEC Form D): $14.4M sold; issuer “ENDRA Life Sciences Inc.”. Verified from the SEC filing. SEC filing ↗
Funding and NIH signals
- SEC Form D raise Raised $14.4M (Form D filed Oct 24, 2025). SEC Form D 0001681682-25-000004 (Oct 24, 2025)
Evidence (1 event)
- Oct 24, 2025 · SEC Form D 0001681682-25-000004
Name of Issuer: ENDRA Life Sciences Inc.; CIK: 1681682; Address: Ann Arbor, MI; Submission type: D; Filing date: 2025-10-24; Industry Group: Biotechnology; Date of First Sale: 2025-10-10; Types of Securities Offered: Equity, Other (Prefunded and Common Warrants to purchase shares of Common Stock); Business combination transaction: false; Total Offering Amount: 14402880; Total Amount Sold: 14402880; Federal exemptions: 06c
- Oct 24, 2025 · SEC Form D 0001681682-25-000004